🏠
Author: alexander-a-tin.bsky.social (did:plc:uxvc5nwyutzf5gtu4x7jqyk3)

Collections

DID Doc

success:
true
identity:
verificationMethod:
service:

Record🤔

uri:
"at://did:plc:uxvc5nwyutzf5gtu4x7jqyk3/app.bsky.feed.post/3l4iznxkneq23"
cid:
"bafyreigjk5ccsusl5qpl3u5k2snqmdvaijurgaeuahmmeb3j3qp2fleuxy"
value:
text:
"Mark your calendars

FDA says it will ask its outside vaccine advisers to weigh in next month on 

"pandemic preparedness for highly pathogenic avian influenza virus including considerations for vaccine composition for (H5) vaccines"

public-inspection.federalregister.gov/2024-21431.pdf"
$type:
"app.bsky.feed.post"
embed:
$type:
"app.bsky.embed.images"
images:
  • alt:
    "A screenshot of text that reads in part: "SUPPLEMENTARY INFORMATION: Agenda: The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing and/or video conferencing platform. On October 10, 2024, the Committee will meet in open session to discuss the following three separate topics. Under Topic I, the Committee will discuss and make recommendations on the strain selection for the influenza virus vaccines for the 2025 southern hemisphere influenza season. Under Topic II, the Committee will discuss pandemic preparedness for highly pathogenic avian influenza virus including considerations for vaccine composition for (H5) vaccines. Under Topic III, the Committee will hear an overview of the research programs in the Laboratory of Pediatric & Respiratory Viral Diseases and the Laboratory of DNA Viruses in the Division of Viral Products, Office of Vaccines Research and Review, CBER. After the open session, the meeting will be closed to the public"
    image:
    View blob content
    $type:
    "blob"
    ref:
    $link:
    "bafkreigtb5pef43idkuvgqfzf5vosocmeyhej5k44bd6cgjxd2etlhjfrq"
    mimeType:
    "image/jpeg"
    size:
    343623
    aspectRatio:
    width:
    680
    height:
    634
langs:
  • "en"
facets:
createdAt:
"2024-09-19T12:17:26.366Z"